Literature DB >> 20336692

Proteus in the world of proteins: conformational changes in protein kinases.

Matthias Rabiller1, Matthäus Getlik, Sabine Klüter, André Richters, Sandra Tückmantel, Jeffrey R Simard, Daniel Rauh.   

Abstract

The 512 protein kinases encoded by the human genome are a prime example of nature's ability to create diversity by introducing variations to a highly conserved theme. The activity of each kinase domain is controlled by layers of regulatory mechanisms involving different combinations of post-translational modifications, intramolecular contacts, and intermolecular interactions. Ultimately, they all achieve their effect by favoring particular conformations that promote or prevent the kinase domain from catalyzing protein phosphorylation. The central role of kinases in various diseases has encouraged extensive investigations of their biological function and three-dimensional structures, yielding a more detailed understanding of the mechanisms that regulate protein kinase activity by conformational changes. In the present review, we discuss these regulatory mechanisms and show how conformational changes can be exploited for the design of specific inhibitors that lock protein kinases in inactive conformations. In addition, we highlight recent developments to monitor ligand-induced structural changes in protein kinases and for screening and identifying inhibitors that stabilize enzymatically incompetent kinase conformations.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20336692     DOI: 10.1002/ardp.201000028

Source DB:  PubMed          Journal:  Arch Pharm (Weinheim)        ISSN: 0365-6233            Impact factor:   3.751


  25 in total

1.  Structural basis for basal activity and autoactivation of abscisic acid (ABA) signaling SnRK2 kinases.

Authors:  Ley-Moy Ng; Fen-Fen Soon; X Edward Zhou; Graham M West; Amanda Kovach; Kelly M Suino-Powell; Michael J Chalmers; Jun Li; Eu-Leong Yong; Jian-Kang Zhu; Patrick R Griffin; Karsten Melcher; H Eric Xu
Journal:  Proc Natl Acad Sci U S A       Date:  2011-12-12       Impact factor: 11.205

Review 2.  Computational methods in drug discovery.

Authors:  Gregory Sliwoski; Sandeepkumar Kothiwale; Jens Meiler; Edward W Lowe
Journal:  Pharmacol Rev       Date:  2013-12-31       Impact factor: 25.468

3.  Molecular mechanism of selectivity among G protein-coupled receptor kinase 2 inhibitors.

Authors:  David M Thal; Raymond Y Yeow; Christian Schoenau; Jochen Huber; John J G Tesmer
Journal:  Mol Pharmacol       Date:  2011-05-19       Impact factor: 4.436

4.  Natural-product-derived fragments for fragment-based ligand discovery.

Authors:  Björn Over; Stefan Wetzel; Christian Grütter; Yasushi Nakai; Steffen Renner; Daniel Rauh; Herbert Waldmann
Journal:  Nat Chem       Date:  2012-12-02       Impact factor: 24.427

Review 5.  Structural and mechanistic insights into the bifunctional enzyme isocitrate dehydrogenase kinase/phosphatase AceK.

Authors:  Jimin Zheng; Susan P Yates; Zongchao Jia
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2012-09-19       Impact factor: 6.237

6.  Global analysis of protein structural changes in complex proteomes.

Authors:  Yuehan Feng; Giorgia De Franceschi; Abdullah Kahraman; Martin Soste; Andre Melnik; Paul J Boersema; Patrizia Polverino de Laureto; Yaroslav Nikolaev; Ana Paula Oliveira; Paola Picotti
Journal:  Nat Biotechnol       Date:  2014-09-14       Impact factor: 54.908

7.  Targeted kinase selectivity from kinase profiling data.

Authors:  Francesca Milletti; Johannes C Hermann
Journal:  ACS Med Chem Lett       Date:  2012-03-14       Impact factor: 4.345

8.  Protein conformation ensembles monitored by HDX reveal a structural rationale for abscisic acid signaling protein affinities and activities.

Authors:  Graham M West; Bruce D Pascal; Ley-Moy Ng; Fen-Fen Soon; Karsten Melcher; H Eric Xu; Michael J Chalmers; Patrick R Griffin
Journal:  Structure       Date:  2013-01-03       Impact factor: 5.006

9.  Structure-based discovery of the first allosteric inhibitors of cyclin-dependent kinase 2.

Authors:  Giulio Rastelli; Andrew Anighoro; Martina Chripkova; Laura Carrassa; Massimo Broggini
Journal:  Cell Cycle       Date:  2014-06-09       Impact factor: 4.534

Review 10.  Discoidin domain receptor 1 (DDR1) kinase as target for structure-based drug discovery.

Authors:  Sandeepkumar Kothiwale; Corina M Borza; Edward W Lowe; Ambra Pozzi; Jens Meiler
Journal:  Drug Discov Today       Date:  2014-10-07       Impact factor: 7.851

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.